Literature DB >> 17543683

A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences.

Birgitta Sigvant1, Katarina Wiberg-Hedman, David Bergqvist, Olov Rolandsson, Bob Andersson, Elisabeth Persson, Eric Wahlberg.   

Abstract

OBJECTIVE: A population-based point-prevalence study was conducted to determine the prevalence of peripheral arterial disease (PAD) in Sweden, with special attention to critical limb ischemia and sex differences.
METHODS: An age-standardized randomly selected population sample of 8000 women and men, aged 60 to 90 years, from four different regions in Sweden was invited to participate. The sample had the same age and gender distribution as the Swedish population in this age group. Participating subjects completed questionnaires on medical history, present medication, and symptoms, and their ankle-brachial index (ABI) was measured. Subjects were analyzed for presence of PAD according to reported symptoms and an ABI<0.9.
RESULTS: A total of 5080 subjects were included, giving a participation rate of 64%. The prevalence of any PAD, asymptomatic PAD, intermittent claudication, and severe limb ischemia was, respectively, 18% (95% confidence interval [CI], 16% to 20%) 11% (9% to 13%), 7% (6.5 to 7%) and 1.2% (1% to 1.5%). Women had a higher prevalence than men when PAD was diagnosed with ABI only; that is, asymptomatic PAD (12.6% vs 9.4%, P=.03) and severe limb ischemia (1.5% vs 0.8%, P<.008). The prevalence of any PAD was 7.9% in the age group 60 to 65 years and increased to 47.2% among the age group 85 to 90 years. Severe limb ischemia occurred in 0.3% in the youngest age group, was highest in the age group 80 to 84 years at 3.3%, and declined to 2.5% among the oldest. The prevalence of PAD differed between regions (P<.0001).
CONCLUSIONS: PAD is common in Sweden, and almost a fifth of all elderly individuals have some stage of this disease. Women are more often afflicted than men. The prevalence of severe ischemia, as a measure of critical limb ischemia, is about 1% the population.

Entities:  

Mesh:

Year:  2007        PMID: 17543683     DOI: 10.1016/j.jvs.2007.02.004

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  80 in total

1.  Gender differences in the prevalence and management of metabolic syndrome and its components in patients with peripheral artery disease.

Authors:  Raha Nael; Polly S Montgomery; Kristy J Scott; Steve M Blevins; Andrew W Gardner
Journal:  Angiology       Date:  2011-04-20       Impact factor: 3.619

2.  Subtraction CT angiography for the diagnosis of iliac arterial steno-occlusive disease.

Authors:  Michiko Suzuki; Ryoichi Tanaka; Kunihiro Yoshioka; Akihiko Abiko; Shigeru Ehara
Journal:  Jpn J Radiol       Date:  2015-12-18       Impact factor: 2.374

Review 3.  Gender Differences in Peripheral Vascular Disease.

Authors:  Kristofer Schramm; Paul J Rochon
Journal:  Semin Intervent Radiol       Date:  2018-04-05       Impact factor: 1.513

Review 4.  PAD in women: the ischemic continuum.

Authors:  Amy West Pollak
Journal:  Curr Atheroscler Rep       Date:  2015-06       Impact factor: 5.113

Review 5.  Peripheral artery disease (PAD) screening in the asymptomatic population: why, how, and who?

Authors:  Henrik Sillesen; Erling Falk
Journal:  Curr Atheroscler Rep       Date:  2011-10       Impact factor: 5.113

Review 6.  [Recanalization of the lower leg: PTA or stent?].

Authors:  S Müller-Hülsbeck
Journal:  Radiologe       Date:  2010-01       Impact factor: 0.635

7.  Effect of nitric oxide on neointimal hyperplasia based on sex and hormone status.

Authors:  Melissa E Hogg; Vinit N Varu; Ashley K Vavra; Daniel A Popowich; Monisha N Banerjee; Janet Martinez; Qun Jiang; Joseph E Saavedra; Larry K Keefer; Melina R Kibbe
Journal:  Free Radic Biol Med       Date:  2011-01-21       Impact factor: 7.376

8.  A risk score assessment tool for peripheral arterial disease in women: From the National Health and Nutrition Examination Survey.

Authors:  Hend Mansoor; Islam Y Elgendy; Renessa S Williams; Verlin W Joseph; Young-Rock Hong; Arch G Mainous
Journal:  Clin Cardiol       Date:  2018-08-17       Impact factor: 2.882

9.  Outcomes of endovascular lower extremity interventions depend more on indication than physician specialty.

Authors:  Justin R Wallace; Theodore Yuo; Luke Marone; Rabih A Chaer; Michel S Makaroun
Journal:  J Vasc Surg       Date:  2013-10-03       Impact factor: 4.268

10.  The Viborg Vascular (VIVA) screening trial of 65-74 year old men in the central region of Denmark: study protocol.

Authors:  Nikolaj Grøndal; Rikke Søgaard; Eskild W Henneberg; Jes S Lindholt
Journal:  Trials       Date:  2010-05-27       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.